YILMAZ ORAL, D. Et Al. 2021. Mirabegron, A Selective beta (3) -Adrenoceptor Agonist Causes an Improvement in Erectile Dysfunction in Diabetic Rats. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.129, no.4 , 296-302.

YILMAZ ORAL, D., KAYA SEZGİNER, E., Askin, D., Hamurtekin, Y., & GÜR, S., (2021). Mirabegron, A Selective beta (3) -Adrenoceptor Agonist Causes an Improvement in Erectile Dysfunction in Diabetic Rats. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.129, no.4, 296-302.

YILMAZ ORAL, DİDEM Et Al. "Mirabegron, A Selective beta (3) -Adrenoceptor Agonist Causes an Improvement in Erectile Dysfunction in Diabetic Rats," EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.129, no.4, 296-302, 2021

YILMAZ ORAL, DİDEM Y. Et Al. "Mirabegron, A Selective beta (3) -Adrenoceptor Agonist Causes an Improvement in Erectile Dysfunction in Diabetic Rats." EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.129, no.4, pp.296-302, 2021

YILMAZ ORAL, D. Et Al. (2021) . "Mirabegron, A Selective beta (3) -Adrenoceptor Agonist Causes an Improvement in Erectile Dysfunction in Diabetic Rats." EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.129, no.4, pp.296-302.

@article{article, author={DİDEM YILMAZ ORAL Et Al. }, title={Mirabegron, A Selective beta (3) -Adrenoceptor Agonist Causes an Improvement in Erectile Dysfunction in Diabetic Rats}, journal={EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES}, year=2021, pages={296-302} }